Nuvation Bio earnings were -$532.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest NUVB earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$41.2M, down 91.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, NUVB reported annual earnings of -$75.8M, with -27.3% growth. The next NUVB earnings date is Feb 26, 2025.
On NUVB's earnings call on Invalid Date, Nuvation Bio (NYSE: NUVB) reported Q3 2024 earnings per share (EPS) of -$0.15, up 66.67% year over year. Total NUVB earnings for the quarter were -$41.21 million. In the same quarter last year, Nuvation Bio's earnings per share (EPS) was -$0.09.
The next NUVB earnings date is Invalid Date. Add NUVB to your watchlist to be reminded of Nuvation Bio's next earnings date.
What was NUVB's earnings growth in the past year?
As of Nuvation Bio's earnings date in Invalid Date, Nuvation Bio's earnings has grown year over year. NUVB earnings in the past year totalled -$532.28 million.
Is Nuvation Bio profitable or losing money?
As of the last Nuvation Bio earnings report, Nuvation Bio is currently losing money. Nuvation Bio's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$532.28 million, a 542.39% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.